Medical News

RSS

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

Individuals between 30 and 80 years of age, who have had a transient ischemic attack (TIA) or non-severe stroke within the past 30 days, and who cannot be treated surgically, may be eligible to participate in a Phase III clinical trial of a minimally invasive stenting procedure at the Cedars-Sinai Neurovascular Center. The study will focus specifically on patients who have had an intracranial artery narrowed by at least 70 percent and who are experiencing recurrent strokes or TIAs despite being on anti-clotting medication.

19 Mar 2010

CIO Healthcare Summit to be sponsored by Zanett Healthcare

Zanett Healthcare is pleased to announce that it will sponsor the CIO Healthcare Summit, a leading gathering for CIOs, analysts and industry-thought leaders within healthcare information technology. The CIO Healthcare Summit will be held at the InterContinental Montelucia Resort in Scottsdale, Arizona on May 9-12, 2010.

19 Mar 2010

Comprehensive healthcare reform: March Madness in Congress

"It's March Madness in Congress as well as on the nation's basketball courts this week, so let's look at the past performance charts to see how the two teams have performed on the big challenge of comprehensive healthcare reform.

19 Mar 2010

ViroPharma to present Cinryze data at Southern European Allergy Society congress

ViroPharma Incorporated today announced the presentation of two abstracts relating to Cinryze™ (C1 esterase inhibitor [human]) therapy at the First International Congress of the Southern European Allergy Society in Florence, Italy.

19 Mar 2010

CPEX Pharmaceuticals' Phase 2a Nasulin trial fails, Arcadia Capital Advisors issues statement

Richard S. Rofe, who serves as Managing Director for Arcadia Capital Advisors, LLC, and is part of a shareholder group that includes Arcadia with a 9.97 percent ownership interest in CPEX Pharmaceuticals, Inc.,, commented on CPEX's recent announcement of failed Phase 2a Nasulin study results.

19 Mar 2010

ViroPharma launches 'Ryze Above' for patients with HAE enrolled in CINRYZESolutions support program

ViroPharma Incorporated today announced the launch of 'Ryze Above' (www.ryzeabove.com), an exclusive patient resources program within the company's patient support program, CINRYZESolutions®. The Ryze Above program was created for HAE patients prescribed Cinryze, the first and only drug specifically approved to help prevent swelling and/or painful attacks in teenagers and adults with HAE.

19 Mar 2010

Valeant Pharmaceuticals International advances dermatology presence in Brazilian market

Valeant Pharmaceuticals International today announced that it has signed a binding agreement to acquire a private branded generics and over the counter company located in Brazil for approximately US$28 million. A large portion of the company's product portfolio is in dermatology and the company had annual sales of approximately US$19 million in 2009.

19 Mar 2010

Synergy Pharmaceuticals commences dosing in Phase IIa clinical trial of SP-304 in CC patients

Synergy Pharmaceuticals, Inc., a developer of new drugs to treat gastrointestinal disorders and diseases, announced today the initiation of dosing in a Phase IIa clinical trial of SP-304 in patients with chronic constipation (CC). This is a Phase IIa, randomized, double-blind, placebo-controlled, 14-day repeat, oral, dose-escalation study in patients with chronic constipation.

19 Mar 2010

Kaiser Permanente to invest nearly $2M to open new medical office in Lawrenceville

Located in Building 100 at 455 Philip Blvd., the new medical office will become Kaiser Permanente's third location in Gwinnett County, along with its Sugar Hill-Buford and Gwinnett locations. The Lawrenceville location is the third new Kaiser Permanente medical center to open in the past six months, along with East Cobb and Downtown Decatur.

19 Mar 2010

Maxine Morgan Eyewear unveils comprehensive line of specialized lenses, frames and specialty products

Maxine Morgan Eyewear unveils its comprehensive line of specialized lenses, frames and specialty products with a major presence here at the International Vision Expo East, booth # MS1060, medical science pavilion, in the Jacob K. Javits Convention Center.

19 Mar 2010

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Activeion Cleaning Solutions LLC, Rogers, MN USA is proud to announce its new European subsidiary, Activeion (Europe) GmbH. Activeion (Europe) GmbH will distribute and market the ionator EXP™ throughout Europe, the Middle East and Africa. Activeion's ionator EXP™ is a handheld, on-demand, completely chemical-free cleaning tool that activates and converts tap water into ionised water, a powerful dirt-removing and bacteria-killing product.

19 Mar 2010

Trauma patients with undiagnosed Helicobacter infections: Some drugs may not be effective

A Kansas State University study aimed at alleviating intestinal damage in trauma patients digressed to an important finding that could affect medication given to the individuals.

19 Mar 2010

Hip-hop and neuroscience

The tweets flew fast and furious at the famous South By Southwest Music, Film, & Interactive Festival in Austin, Texas when "Listen To Your Brain" began playing on the big screen.

19 Mar 2010

One-third of patients hospitalized on weekends receive needed major procedures on day of admission

Of the 8 million patients who were admitted to U.S. hospitals on weekends in 2007, approximately one-third received needed major procedures on the day of admission, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. In comparison, patients who were admitted on weekdays received 65 percent of all major procedures on their first day in the hospital.

19 Mar 2010

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

Most kidney donors and recipients are in favor of exchanging personal health information that may influence success before scheduling a living organ donor transplant, while healthcare professionals are more reluctant, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

19 Mar 2010

Community-driven approaches needed for reducing cancer-death disparities

Cancer death rates for African-Americans far exceed non-Hispanic Caucasians in the United States, and only community-driven approaches to reducing health disparities will lessen the gap, says Edward Partridge, M.D., president-elect of the American Cancer Society (ACS) National Board of Directors and director of the University of Alabama at Birmingham (UAB) Comprehensive Cancer Center.

19 Mar 2010

Teva Pharmaceutical Industries receives right to market generic version of Schering’s Temodar

Teva Pharmaceutical Industries Ltd. announced today that the parties to the patent litigation regarding Barr’s U.S. generic version of Schering’s Temodar® have entered into an agreement pending resolution of Schering’s appeal to the Federal Circuit of the U.S. District Court’s decision holding the ‘291 Patent unenforceable.

19 Mar 2010

Collaborative project yields aqueous solubility data for over 20,000 compounds in NIH Molecular Library

A collaborative project between Sanford-Burnham Medical Research Institute at Lake Nona and Analiza, Inc. has yielded aqueous solubility data for over 20,000 compounds in the NIH Molecular Library within the first 90 days of screening and characterization.

19 Mar 2010

Propeller tears right arm, UT Southwestern Medical Center surgeon re-attaches

"The propeller cut through the skin, muscle, tendons and bone and had removed portions of the bone," he recalled. "Basically, she had severed her arm, and it was attached only by some skin, tendon, nerve and artery."

19 Mar 2010

White paper describes health and economic burden of diabetes on Americans

PositiveID Corporation announced today that it has published a white paper entitled “Fixing the Black Hole in Diabetes Management,” which describes the health and economic burden of diabetes on Americans and our economy.

19 Mar 2010

Medical News

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

CIO Healthcare Summit to be sponsored by Zanett Healthcare

Comprehensive healthcare reform: March Madness in Congress

ViroPharma to present Cinryze data at Southern European Allergy Society congress

CPEX Pharmaceuticals' Phase 2a Nasulin trial fails, Arcadia Capital Advisors issues statement

ViroPharma launches 'Ryze Above' for patients with HAE enrolled in CINRYZESolutions support program

Valeant Pharmaceuticals International advances dermatology presence in Brazilian market

Synergy Pharmaceuticals commences dosing in Phase IIa clinical trial of SP-304 in CC patients

Kaiser Permanente to invest nearly $2M to open new medical office in Lawrenceville

Maxine Morgan Eyewear unveils comprehensive line of specialized lenses, frames and specialty products

Activeion Cleaning Solutions announces new European subsidiary, Activeion GmbH

Trauma patients with undiagnosed Helicobacter infections: Some drugs may not be effective

Hip-hop and neuroscience

One-third of patients hospitalized on weekends receive needed major procedures on day of admission

Kidney donors and recipients favor exchange of personal health information before transplantation, but not physicians

Community-driven approaches needed for reducing cancer-death disparities

Teva Pharmaceutical Industries receives right to market generic version of Schering’s Temodar

Collaborative project yields aqueous solubility data for over 20,000 compounds in NIH Molecular Library

Propeller tears right arm, UT Southwestern Medical Center surgeon re-attaches

White paper describes health and economic burden of diabetes on Americans

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News